How much does Biktarvy (Bictegravir Sodium, Emtricitabine and Tenofovir Alafenamide Fumarate Tablets) Cost& price without insurance in China?
Biktarvy® is the commercial brand name of Bictegravir Sodium, Emtricitabine and Tenofovir Alafenamide Fumarate Tablets, an orally active single-tablet fixed-dose combination anti-HIV agent developed by Gilead Sciences. Bictegravir inhibits HIV integrase to block viral gene integration, while emtricitabine and tenofovir alafenamide suppress viral reverse transcription, jointly restraining HIV replication.
Main Indications
Treatment of human immunodeficiency virus type 1 (HIV-1) infection in adult patients without prior antiretroviral treatment experience;
Alternative maintenance therapy for eligible virologically suppressed HIV-1 infected adults.
Common Side Effects
Common mild adverse reactions: Headache, fatigue, diarrhea and nausea.
Laboratory abnormalities: Rare transient mild creatinine elevation and lipid fluctuation.
Severe but manageable risks: Severe hypersensitivity reaction, immune reconstitution inflammatory syndrome and lactic acidosis.
Approval Status in China
Biktarvy® (Bictegravir 50mg/Emtricitabine 200mg/Tenofovir Alafenamide 25mg per tablet, domestic Chinese brand name: Biyiwei) was officially approved for marketing in China in 2019. It is currently a prescription drug included in China’s Category B medical insurance.
Buy Biktarvy (Bictegravir Sodium, Emtricitabine and Tenofovir Alafenamide Fumarate Tablets) online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.
